VTRS News and Press, Viatris Inc. From 10/10/23

Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023 PR Newswire PITTSBURGH , Oct. 10, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its third quarter 2023 financial results on Tuesday, November 7 after the ...

2023-10-08 09:45:00 ET With bond yields rising and interest rates expected to remain elevated for several more quarters, value stocks are starting to look mighty enticing. Value stocks are equities that trade at low earnings multiples, price-to-sales multiples, or book values relative to th...

2023-10-08 08:15:00 ET For income-seeking investors, the only thing better than a solid dividend stock is a beaten-down one whose shares can be bought on the dip. And while the market has largely recovered this year, some dividend-paying corporations missed the memo and have substantially l...

2023-10-04 12:38:18 ET More on Novo Nordisk Novo Nordisk: DCF Analysis Suggests Significant Undervaluation Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Novo Nordisk: What The Stock Split Means For Traders And Investors Novo Nordisk gains aft...

2023-10-04 12:24:03 ET More on Novo Nordisk Novo Nordisk: DCF Analysis Suggests Significant Undervaluation Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Novo Nordisk: What The Stock Split Means For Traders And Investors Novo Nordisk gains aft...

2023-10-02 08:57:00 ET U.S. stock index futures on Monday were largely lower , as Wall Street kicked off a new month and the final quarter of 2023. The benchmark S&P 500 ( SP500 ) on Friday slumped to a nearly 5% loss for September, marking its worst monthly performance since De...

2023-10-02 06:35:13 ET More on Viatris Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss Why 5%-Yielding Viatris Hasn't Doubled Yet Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market Novo Nordisk underperforms a...

Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA PR Newswire Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Compan...

2023-10-01 12:00:03 ET More on Novo Nordisk Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss Novo Nordisk: DCF Analysis Suggests Significant Undervaluation Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Viatris a...

2023-09-30 07:58:00 ET If you're investing $25,000 in your stock portfolio, then getting that investment to be worth $1 million over time is no simple task. Odds are, you'll have to wait decades for that investment to grow 40 times its original value, while also likely outperforming the mar...